Evidence map›Paper›PMID 39995930›Full record

ArticleHeliyon2025

Illicit drug use derived from wastewater-based epidemiology in Iran, their removal during wastewater treatment, and occurrence in receiving waters.

Anvar Asadi, Shabnam Zarei, Nebile Daglioglu, Evsen Yavuz Guzel, Neda Ravankhah

Abstract read
In one paragraph

Article in Heliyon, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anvar AsadiEnvironmental Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Shabnam Zarei, Department of Environmental Health Engineering, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Nebile DagliogluInstitute of Forensic Sciences, Department of Forensic Toxicology, Ankara University, Ankara, Turkey.
Evsen Yavuz GuzelDepartment of Basic Science, Faculty of Fisheries, Cukurova University, Adana, Turkey.
Neda Ravankhah, Department of Environmental Health Engineering, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to measure the licit and illicit drug concentrations in wastewater treatment plants (WWTPs), their removal efficiency, and their consumption rate by wastewater-based epidemiology (WBE) approach. A 2-season monitoring program was undertaken for the first time in Iran. Residues of licit and illicit drugs (amphetamine, 3,4-methylenedioxyamphetamine, methamphetamine, codeine, 3,4-methylenedioxymethamphetamine, heroin, cocaine, and methadone) and major metabolites (benzoylecgonine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and 6-monoacetylmorphine) were analyzed by LC-MS/MS in composite sampling after solid phase extraction method. These analytes were also measured in rivers vicinity to selected cities. The detected concentration in raw wastewater was converted into the quantity of illicit drugs per capita using back-calculation. There was no detection of cocaine, its metabolite benzoylecgonine, or 3,4-methylenedioxymethamphetamine in any of the samples. Among the analytes measured, morphine and codeine exhibited the most prevalent occurrence and highest concentration levels in all the samples. Heroin was the main illicit drugs used in the studied population with a mean consumption rate of 6108 and 158 mg/day/1000 inh. in cold and warm seasons, respectively. The removal efficiencies of drugs during wastewater treatment ranged from 3.5 % (3,4-methylenedioxyamphetamine) to >99 % (amphetamine, methamphetamine, and codeine); however, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine demonstrated a negative removal within WWTPs. This study provides crucial insights into the consumption of illicit drugs in Iran, as well as the release of illicit drugs and their metabolites through WWTPs.

Indexed as

Consumption rateHeroinIllicit drugsLC-MS/MSWastewater-based epidemiology

Identifiers

PMID39995930
PMCPMC11849611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.